TEVA
Teva Pharmaceutical Industries Limited · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-03
Figures on this page computed 2026-11-08 12:41 UTC
Last close
41.85USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-03
34.6xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-03
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
- 10-K for 2025, filed 2026-02-03
- 10-K for 2025, filed 2026-02-03
- 10-K for 2025, filed 2026-02-03
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-03
- 10-Q for 2025, filed 2026-11-03
8.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
- 10-K for 2025, filed 2026-02-03
- 10-K for 2025, filed 2026-02-03
6.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
- 10-K for 2025, filed 2026-02-03
- 10-K for 2025, filed 2026-02-03
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
- 10-K for 2025, filed 2026-02-03
- 10-Q for 2025, filed 2026-11-03
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Safety is the furthest below its sector's middle: 0.29 against 0.53 on the market's range.
- Growth0.7%55 of 100, above its sector
- Returns on capital17.8%76 of 100, above its sector
- Margins51.8%67 of 100, above its sector
- Price34.6x26 of 100, below its sector
- Safety1.0429 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
What it sells, to whom
lens 8 of 9What it sells
6Where it sells it
3Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.
6 segments, 3 places and 0 named customers, each as the filer published it.
6 segments, 3 places and 0 named customers, each as the filer published it.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-03
United States9,186,000,000
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- UNIT_USD
Europe5,040,000,000
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- UNIT_USD
International Markets2,162,000,000
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- UNIT_USD
Other Activities870,000,000
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- UNIT_USD
Corporaten/a
Not held.
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- UNIT_USD
All Othern/a
Not held.
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- UNIT_USD
United States Segment9,186,000,000
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
Europe Segment5,040,000,000
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD
International Markets2,162,000,000
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2025
- Accession
- 0001193125-26-034532
- Reported in
- USD